Saudi Jada: Pandemic Resulted in $266 Million Worth of Investment Opportunities in 2020

Adel Al Ateeq, CEO of Jada Fund of Funds Co. (Jada) (Photo: Asharq Al-Awsat).
Adel Al Ateeq, CEO of Jada Fund of Funds Co. (Jada) (Photo: Asharq Al-Awsat).
TT

Saudi Jada: Pandemic Resulted in $266 Million Worth of Investment Opportunities in 2020

Adel Al Ateeq, CEO of Jada Fund of Funds Co. (Jada) (Photo: Asharq Al-Awsat).
Adel Al Ateeq, CEO of Jada Fund of Funds Co. (Jada) (Photo: Asharq Al-Awsat).

Adel Al Ateeq, CEO of Jada Fund of Funds Co. (Jada), said that the goal of the company was to stimulate investment in private equity and venture capital funds, thus financing the growth of the small and medium enterprises (SMEs) sector in Saudi Arabia in a sustainable manner.

“In Jada, we are not only looking for profit, but we are forming a nest for an entire sector, the investment sector, with the aim of enhancing its positive contribution to the Saudi economy,” Al Ateeq told Asharq Al-Awsat in an exclusive interview.

Jada – the Saudi Fund of Funds - was approved by the Saudi Council of Ministers in 2016 and launched in 2019. Al Ateeq said that the company - founded by the Public Investment Fund (PIF) with a capital of 4 billion riyals (one billion dollars) - is focusing on benefiting from the diversity of resources and the multiplicity of sectors, activating the human potential and attracting foreign investments.

Asked about the repercussions of the Covid-19 pandemic on the investment climate in 2020, he said: “Certainly, it was a difficult year health wise and economically for the entire world, and undoubtedly, everyone felt these effects… Here, experiences and right insights play their role, allowing challenges to be transformed into opportunities.”

He explained: “The challenges of the Covid-19 pandemic brought with it investment opportunities in many sectors, especially those related to technology and entrepreneurship. For example, the quarterly report of the Saudi Venture Capital and Private Equity Association showed that investments in SMEs grew by 300 percent during the second quarter of 2020 compared to the same period last year.”

Al Ateeq noted that despite the repercussions of the pandemic, Jada implemented “many excellent partnerships.”

“So far, we have invested in 14 private equity and venture capital funds, worth up to one billion riyals (USD 266.6 million), and now we are focusing our goals on continuing impactful investment, especially as the world begins to recover from this pandemic,” he said.

Al Ateeq continued: “We are looking forward to 2021 with great ambition, and we are planning to implement quality and impactful investments that continue to ensure the flow of good financial returns and enhance Jada’s contribution to the Saudi economy.”

The CEO of Jada underlined the importance of partnerships with the different Saudi institutions.

He said the company was working with the Saudi Capital Market Authority and other regulators to develop frameworks and to transfer successful global experiences to investment funds within the Kingdom in order to accelerate their growth and improve their performance.

Managing, dealing with, and assessing risk is an essential feature of the experts who work with Jada, and those who manage the funds the company invests in, he noted.

Asked about the company’s investment priorities, Al Ateeq said: “If we review the agreements that were concluded, you will notice that we focus on certain sectors. We have concluded partnership agreements with investment funds to finance emerging companies in the technology, entertainment and industry sectors, as well as the food and beverage sector. At the same time, we are open to all sectors, and what matters to us is the quality, specifically the sectors that have the greatest impact on the level of economic development and job creation.”

Jada’s investment portfolio currently includes more than 240 SMEs that have provided more than 1,125 job opportunities in the Kingdom, he noted.

“We are not a legislative body, but we are able to contribute to the development of sectors that we think are most beneficial to the Saudi economy by approaching the issue from the investor’s point of view. Therefore, through our investments, we stress the importance of applying the most important global ethical standards,” Al Ateeq told Asharq Al-Awsat.

He revealed that the company has benefited from the experiences of funds in Western and European countries, and some Asian countries, such as Singapore and Hong Kong.

“But each country has its own experience; and here in the Fund of Funds Co. we have our own experience that suits the Saudi economy, the nature of investments and the SMEs in Saudi Arabia,” he said.

On the factors that help Jada achieve its goals, Al Ateeq said that those include “our leadership’s support, the Kingdom’s focus on the importance of investment, and Vision 2030, which lays the foundations for all these trends, in addition to the vitality of Saudi Arabia’s economy, the diversity of its resources, and the availability of experts and managers who can be described as professionals, especially from within the country.”

In addition, Jada’s CEO also cited the great progress in the Kingdom’s legal structures, the development of the culture of initiative and innovation, the establishment of private enterprises, and the determination to empower the private sector.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.